Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Novocure Ltd (NVCR)  
$17.98 1.51 (9.17%) as of 4:30 Mon 5/13


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 101,800,000
Market Cap: 1.83(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $11.13 - $82.51
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   NovoCure is an oncology company with a platform technology called Tumor Treating Fields. Co. is focusing on commercial adoption of Optune and NovoTTF-100L. Optune is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with newly diagnosed glioblastoma (GBM) in combination with temozolomide, a chemotherapy drug, and for adult patients with GBM following confirmed recurrence after chemotherapy as monotherapy treatment. Co. also has approval to market Optune for the treatment of GBM in the European Union, Japan and certain other countries. NovoTTF-100L is approved by the FDA to treat malignant pleural mesothelioma in combination with chemotherapies.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 10,224 10,224 13,200 434,026
Total Sell Value $164,332 $164,332 $235,406 $41,239,900
Total People Sold 2 2 4 10
Total Sell Transactions 6 6 11 52
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 906
  Page 9 of 37  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Leung Gabriel Director   –       •      –    2021-06-07 4 OE $31.45 $31,450 D/D 1,000 73,045     -
   Benaim Ely Chief Medical Officer   •       –      –    2021-05-27 4 AS $200.00 $366,600 D/D (1,833) 29,054 -45%     
   Benaim Ely Chief Medical Officer   •       –      –    2021-05-27 4 OE $47.56 $87,177 D/D 1,833 30,887     -
   Benaim Ely Chief Medical Officer   •       –      –    2021-05-12 4 AS $180.48 $350,673 D/D (1,943) 29,054 -29%     
   Benaim Ely Chief Medical Officer   •       –      –    2021-05-11 4 AS $180.12 $407,427 D/D (2,262) 30,997 -32%     
   Weinberg Uri Chief Science Officer   •       –      –    2021-05-10 4 AS $189.65 $1,071,523 D/D (5,650) 31,667 -28%     
   Weinberg Uri Chief Science Officer   •       –      –    2021-05-10 4 OE $47.56 $182,916 D/D 3,846 37,317     -
   Benaim Ely Chief Medical Officer   •       –      –    2021-05-10 4 AS $189.65 $347,628 D/D (1,833) 33,259 -28%     
   Benaim Ely Chief Medical Officer   •       –      –    2021-05-10 4 OE $47.56 $87,177 D/D 1,833 35,092     -
   Leung Gabriel Director   –       •      –    2021-05-05 4 AS $199.67 $199,670 D/D (1,000) 72,045 -38%     
   Leung Gabriel Director   –       •      –    2021-05-05 4 OE $31.45 $31,450 D/D 1,000 73,045     -
   Shah Pritesh Chief Commercial Officer   •       –      –    2021-05-05 4 AS $199.67 $257,574 D/D (1,290) 101,272 -38%     
   Shah Pritesh Chief Commercial Officer   •       –      –    2021-05-04 4 S $200.86 $209,493 D/D (1,043) 102,562 34%     
   Shah Pritesh Chief Commercial Officer   •       –      –    2021-05-03 4 OE $204.10 $476,165 D/D 2,333 103,605     -
   Danziger Asaf Chief Executive Officer   •       •      –    2021-04-13 4 AS $196.34 $19,236,323 D/D (97,973) 8,184 -33%     
   Leung Gabriel Director   –       •      –    2021-04-13 4 AS $198.01 $1,193,035 D/D (6,000) 72,045 -33%     
   Leung Gabriel Director   –       •      –    2021-04-13 4 OE $31.45 $188,700 D/D 6,000 78,045     -
   Benaim Ely Chief Medical Officer   •       –      –    2021-04-13 4 AS $200.00 $1,191,600 D/D (5,958) 33,259 -33%     
   Benaim Ely Chief Medical Officer   •       –      –    2021-04-13 4 OE $47.56 $382,397 D/D 5,958 36,733     -
   Doyle William F Executive Chairman   •       •      –    2021-04-13 4 AS $191.26 $18,957,452 D/D (95,000) 555,393 -33%     
   Doyle William F Executive Chairman   •       •      –    2021-04-01 4 S $134.12 $1,063,303 D/D (7,928) 650,393 -7%     
   Doyle William F Executive Chairman   •       •      –    2021-03-31 4 OE $125.25 $1,159,690 D/D 9,259 658,321     -
   Weinberg Uri Chief Science Officer   •       –      –    2021-03-23 4/A AS $140.00 $396,900 D/D (2,835) 33,471     -
   Weinberg Uri Chief Science Officer   •       –      –    2021-03-23 4 AS $140.00 $544,880 D/D (3,892) 36,306 8%     
   Weinberg Uri Chief Science Officer   •       –      –    2021-03-23 4 OE $47.04 $183,080 D/D 3,892 40,198     -
  906 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 37
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us